3,000
Participants
Start Date
April 1, 2019
Primary Completion Date
May 1, 2020
Study Completion Date
May 1, 2020
The first batch of inactivated EV-A71 vaccine (vero cell) producted by 40 L reactor
500 subjects will be randomized to receive the first batch of inactivated EV-A71 vaccine (vero cell) producted by 40 L reactor
The second batch of inactivated EV-A71 vaccine (vero cell) producted by 40 L reactor
500 subjects will be randomized to receive the second batch of inactivated EV-A71 vaccine (vero cell) producted by 40 L reactor
The third batch of inactivated EV-A71 vaccine (vero cell) producted by 40 L reactor
500 subjects will be randomized to receive the third batch of inactivated EV-A71 vaccine (vero cell) producted by 40 L reactor
The first batch of inactivated EV-A71 vaccine (vero cell) producted by 150 L reactor
500 subjects will be randomized to receive the first batch of inactivated EV-A71 vaccine (vero cell) producted by 150 L reactor
The second batch of inactivated EV-A71 vaccine (vero cell) producted by 150 L reactor
500 subjects will be randomized to receive the second batch of inactivated EV-A71 vaccine (vero cell) producted by 150 L reactor
The third batch of inactivated EV-A71 vaccine (vero cell) proudected by 150 L reactor
500 subjects will be randomized to receive the third batch of inactivated EV-A71 vaccine (vero cell) proudected by 150 L reactor
Fengcai Zhu, Nanjing
Wuhan Institute of Biological Products Co., Ltd
INDUSTRY
Jiangsu Province Centers for Disease Control and Prevention
NETWORK